Percutaneous treatment of long superficial femoral artery occlusive disease: Efficacy of the Hemobahn stent-graft

Journal of Endovascular Therapy

Volumn 10, Issue 3, 2003, Pages 619-628

  Bray, Peter J ^a   Robson, William J ^a   Bray, Alan E ^a  

^a Cardio Vascular Centre   (Australia)

Author keywords

Hemobahn endoprosthesis; Occlusive disease; Outcome analysis; Restenosis; Stent graft; Superficial femoral artery; Thrombosis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; COLOR ULTRASOUND FLOWMETRY; DEVICE; FEMALE; FEMORAL ARTERY; FEMOROPOPLITEAL BYPASS; GRAFT FAILURE; GRAFT PATENCY; HEMOBAHNN STENT GRAFT; HUMAN; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESTENOSIS; STENT; THROMBOSIS; VASCULAR ACCESS; VASCULAR PATENCY;

AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS; FEMALE; FEMORAL ARTERY; HUMANS; MALE; MIDDLE AGED; PROSTHESIS DESIGN; STENTS; TIME FACTORS; VASCULAR PATENCY;

EID: 0141590504     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/1545-1550(2003)010<0619:PTOLSF>2.0.CO;2     Document Type: Article

References (46)

1. TASC Working Group. Management of peripheral arterial disease. TransAtlantic Intersociety Consensus (TASC). J Vasc Surg. 2000;31:S1-S296.
2. Murray JG, Apthorp LA, Wilkins RA. Long-segment (> or = 10 cm) femoropopliteal angioplasty: improved technical success and long-term patency. Radiology. 1995;195:158-162.
3. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty. Factors influencing long-term success. Circulation. 1991;83(2 Suppl): 170-180.
4. Lammer J, Dake MD, Bleyn J, et al. Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self-expanding stent-graft. International Trial Study Group. Radiology. 2000;217:95-104.
5. Bolia A, Miles KA, Brennan J, et al. Percutaneous transluminal angioplasty of occlusions of the femoral and popliteal arteries by subintimal dissection. Cardiovasc Intervent Radiol. 1990;13:357-363.
6. Bray AE, Liu WG, Lewis WA, et al. Strecker stent in the femoropopliteal arteries: value of duplex ultrasonography in restenosis assessment. J Endovasc Surg. 1995;2:150-160.
7. McLafferty RB, Moneta GL, Taylor LM, et al. Ability of ankle-brachial index to detect lower-extremity atherosclerotic disease progression. Arch Surg. 1997;132:836-841.
8. Myers KA, Wood SR, Lee V. Vascular ultrasound surveillance after endovascular intervention for occlusive iliac artery disease. Cardiovasc Surg. 2001;9:448-454.
9. Bray A. Commentary: Reporting guidelines: another perspective. J Endovasc Surg. 1995;2:341-342.
10. Gardner AW, Killewich LA. Lack of functional benefits following infrainguinal bypass in peripheral arterial occlusive disease patients. Vasc Med. 2001;6:9-14.
11. Michaels JA. Choice of material for above-knee femoropopliteal bypass graft. Eur J Surg. 1989;76:7-14.
12. Johnson WD, Lee KK. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg. 2000;32:268-277.
13. Hunink MG, Wong JB, Donaldson MC, et al. Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease. Med Decis Making. 1994;14:71-81.
14. Palmaz JC, Laborde JC, Rivera FJ, et al. Stenting of the iliac arteries with the Palmaz stent: experience from a multicenter trial. Cardiovasc Intervent Radiol. 1992;15:291-297.
15. London NJ, Srinivasan R, Naylor AR, et al. Subintimal angioplasty of femoropopliteal artery occlusions: the long-term results. Eur J Vasc Surg. 1994;8:148-155.
16. Krepel VM, van Andel GJ, van Erp WF, et al. Percutaneous transluminal angioplasty of the femoropopliteal artery: initial and long-term results. Radiology. 1985;156:325-328.
17. Johnston KW. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology. 1992;183:767-771.
18. Lammer J. Femoropopliteal artery obstructions: from the balloon to the stent-graft. Cardiovasc Intervent Radiol. 2001;24:73-83.
19. Matsi PJ, Manninen HI, Vanninen RL, et al. Femoropopliteal angioplasty in patients with claudication: primary and secondary patency in 140 limbs with 1-3-year follow-up. Radiology. 1994;191:727-733.
20. Karch LA, Mattos MA, Henretta JP, et al. Clinical failure after percutaneous transluminal angioplasty of the superficial femoral and popliteal arteries. J Vasc Surg. 2000;31:880-887.
21. Weissman NJ, Wilensky RL, Tanguay J, et al. Extent and distribution of in-stent intimal hyperplasia and edge effect in a non-radiation stent population. Am J Cardiol. 2001;88:248-252.
22. Marin ML, Veith FJ, Cynamon J, et al. Effect of polytetrafluoroethylene covering of Palmaz stents on the development of intimal hyperplasia in human iliac arteries. J Vasc Interv Radiol. 1996;7:651-656.
23. Bergeron P, Pinot JJ, Poyen V, et al. Long-term results with the Palmaz stent in the superficial femoral artery. J Endovasc Surg. 1995;2:161-167.
24. Do DD, Triller J, Walpoth BH, et al. A comparison study of self-expandable stents vs balloon angioplasty alone in femoropopliteal artery occlusions. Cardiovasc Intervent Radiol. 1992;15:306-312.
25. Strecker EP, Boos IB, Gottmann D. Femoropopliteal artery stent placement: evaluation of long-term success. Radiology. 1997;205:375-383.
26. Cejna M, Thurnher S, Illiasch H, et al. PTA versus Palmaz stent placement in femoropopliteal artery obstructions: a multicenter prospective randomized study. J Vasc Interv Radiol 2001;12:23-31.
27. Grimm J, Muller-Hulsbeck S, Jahnke T, et al. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol. 2001;12:935-942.
28. Vroegindeweij D, Vos LD, Tielbeek AV, et al. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: a comparative randomized study. Cardiovasc Intervent Radiol. 1997;20:420-425.
29. Virmani R, Kolodgie FD, Dake MD, et al. Histopathologic evaluation of an expanded polytetrafluoroethylene-nitinol stent endoprosthesis in canine iliofemoral arteries. J Vasc Interv Radiol. 1999;10:445-456.
30. Yuan JG, Ohki T, Marin ML, et al. The effect of nonporous PTFE-covered stents on intimal hyperplasia following balloon arterial injury in minipigs. J Endovasc Surg. 1998;5:349-358.
31. Saxon RR, Coffman JM, Gooding JM, et al. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol. 2003;14:303-311.
32. Fischer M, Sakriss U, Stalke J, et al. Hemobahn endoprosthesis: experience with percutaneous placing in the arteria femoralis superficialis [in German]. Zentralbl Chir. 2001;126:138-143.
33. Bauermeister G. Endovascular stent-grafting in the treatment of superficial femoral artery occlusive disease. J Endovasc Ther. 2001;8:315-320.
34. Jahnke T, Andresen R, Muller-Hulsbeck S, et al. Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial. J Vasc Interv Radiol. 2003;14:41-51.
35. Deutschmann HA, Schedlbauer P, Berczi V, et al. Placement of Hemobahn stent-grafts in femoropopliteal arteries: early experience and midterm results in 18 patients. J Vasc Interv Radiol. 2001;12:943-950.
36. Bürger T, Meyer F, Tautenhahn J, et al. Initial experiences with percutaneous endovascular repair of popliteal artery lesions using a new PTFE stent-graft. J Endovasc Surg. 1998;5:365-372.
37. Green RM, Abbott WM, Matsumoto T, et al. Prosthetic above-knee femoropopliteal bypass grafting: five-year results of a randomized trail. J Vasc Surg. 2000;31:417-425.
38. Marin ML, Veith FJ, Cynamon J, et al. Human transluminally placed endovascular stented grafts: preliminary histopathologic analysis of healing grafts in aortoiliac and femoral artery occlusive disease. J Vasc Surg. 1995;21:595-604.
39. Golden MA, Hanson SR, Kirkman TR, et al. Healing of polytetrafluoroethylene arterial grafts is influenced by graft porosity. J Vasc Surg. 1990;11:838-845.
40. Dotter CT. Transluminally placed coilspring endarterial tube grafts. Long-term patency in canine popliteal artery. Invest Radiol. 1969;4:329-332.
41. Laurila J, Brommels M, Standertskjold-Nordenstam CG, et al. Cost-effectiveness of percutaneous transluminal angioplasty (PTA) versus vascular surgery in limb-threatening ischaemia. Int J Angiol. 2000;9:214-219.
42. Gray BH, Sullivan TM, Childs MB, et al. High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg. 1997;25:74-83.
43. Kessel DO, Wijesinghe LD, Robertson I, et al. Endovascular stent-grafts for superficial femoral artery disease: results of 1-year follow-up. J Vasc Interv Radiol. 1999;10:289-296.
44. Lofberg AM, Karacagil S, Ljungman C, et al. Percutaneous transluminal angioplasty of the femoropopliteal arteries in limbs with chronic critical lower limb ischemia. J Vasc Surg. 2001;34:114-121.
45. Robinson BI, Fletcher JP, Tomlinson P, et al. A prospective randomized multicentre comparison of expanded polytetrafluoroethylene and gelatin-sealed knitted Dacron grafts for femoropopliteal bypass. Cardiovasc Surg. 1999;7:214-218.
46. Post S, Kraus T, Muller-Reinartz U, et al. Dacron vs. polytetrafluoroethylene grafts for femoropopliteal bypass: a prospective randomised multicentre trial. Eur J Vasc Endovasc Surg. 2001;22:226-231.